Abigail Smith
0000-0003-0921-1835
Eli Lilly and Company
9 papers found
Refreshing results…
ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic inCasq2−/−Mice
RyR2 Binding of an Antiarrhythmic Cyclic Depsipeptide Mapped Using Confocal Fluorescence Lifetime Detection of FRET
In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Moleculeent-Verticilide
Structure–Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics
Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2–Deficient Hearts
Resolving Bromonitromethane Sourcing by Synthesis: Preparation at the Decagram Scale
Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity
The Formation of Impossible Rings in Macrocyclooligomerizations for Cyclodepsipeptide Synthesis: The 18-from-12 Paradox
RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT
Missing publications? Search for publications with a matching author name.